American Academy of Neurology
12
0
1
9
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 35/100
8.3%
1 terminated/withdrawn out of 12 trials
90.0%
+3.5% vs industry average
17%
2 trials in Phase 3/4
44%
4 of 9 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (12)
Accelerating TMS for Cervical Dystonia
Role: collaborator
Accelerated TMS for Focal Hand Dystonia
Role: collaborator
Cognitive Enhancement in Depression (The COG-D Study)
Role: collaborator
Quantifying the Role of Sensory Systems Processing in Post-Stroke Walking Recovery
Role: collaborator
Neurotoxin and Physical Therapy
Role: collaborator
Reducing the Effects of Aging on Cognition With Therapeutic Intervention of an Oral Nutrient (REACTION): A Pilot Trial
Role: collaborator
Norepinephrine-targeted Therapy for Action Control in Parkinson Disease
Role: collaborator
Acceptability of Palliative Care in Parkinson Disease Care
Role: collaborator
Incorporating teleCBIT Into a Hospital-Based Tic Program
Role: collaborator
Motivational Interviewing to Enhance Adherence of Patients With Psychogenic Non-epileptic Seizures
Role: collaborator
Does Memantine Improve Verbal Memory Task Performance in Subjects With Partial Epilepsy and Memory Dysfunction?
Role: lead
Efficacy of TDCS for Treating Working Memory Dysfunction and Depression in Temporal Lobe Epilepsy
Role: collaborator
All 12 trials loaded